Innovation Pharmaceuticals Eulerpool Ziņas

Innovation Pharmaceuticals Eulerpool News

Innovation Pharmaceuticals Akciju Ziņas

Innovation Pharmaceuticals tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Innovation Pharmaceuticals ziņas mēs apkopojam šeit.

• 28. augusts ·

  Yahoo
  Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024
• 21. jūnijs ·

  Yahoo
  Innovation Pharmaceuticals Provides Update on U.S. Patent Applications Covering Use of Brilacidin in Inflammatory Bowel Diseases, Coronaviruses and Fungal Diseases
• 5. jūnijs ·

  Yahoo
  Innovation Pharma Announces BeaMed Technologies Breakthrough in Development of Fiber Optic Probes for StingRay Laser System; Paves Way for Groundbreaking Integration Testing
• 17. aprīlis ·

  Yahoo
  Innovation Pharmaceuticals Brilacidin Antifungal Research Published in Nature Communications
• 9. aprīlis ·

  Nasdaq
  Weekly Preview: Earnings to Watch This Week 4-9-23 (C, DAL, JPM, TLRY)
• 15. marts ·

  Yahoo
  Innovation Pharmaceuticals Announces New Antifungal Testing of Brilacidin by NIH/NIAID-Affiliated and Other Academic Researchers
• 23. februāris ·

  Yahoo
  Innovation Pharmaceuticals Visits BeaMed; New StingRay Laser System for Epilepsy and Brain Tumors Moving Toward FDA Submission
• 5. februāris ·

  Nasdaq
  Weekly Preview: Earnings to Watch This Week 2-5-23 (DIS, PEP, PYPL)
• 9. janvāris ·

  Yahoo
  Innovation Pharmaceuticals Announces BT BeaMedical Technologies and Shina Systems Ltd. Enter into a Definitive Strategic Development Agreement
• 13. decembris ·

  Yahoo
  Innovation Pharmaceuticals Reports New In Vivo Antifungal Data Showing Brilacidin’s Potential for Treating Fungal Keratitis